Latest filing published 14 Nov 2016 for Acceleron Pharma INC, €168k.
Insider track record
John L. Knopf: trading record in brief
John L. Knopf discloses dealings in Acceleron Pharma Inc to SEC (Form 4). In total, 94 filings cover trades dated from 19 May 2014 to 9 November 2016.
No open-market purchase appears, only 67 sales worth €18.3M. Other entries cover 2 share grants and 24 option exercises. So far in 2016, the count stands at no purchases and 10 sales.
The newest entry dates from 14 November 2016: an option exercise of €168k, in Acceleron Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John L. Knopf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,543 shares@ US$5.881.6% of flowCommon StockSEC:0001179110-16-031541:0
- 37,500 shares@ US$5.281.7% of flowCommon StockSEC:0001179110-16-031541:1
- 9,375 shares@ US$5.280.4% of flowCommon StockSEC:0001179110-16-031541:2
- 15,976 shares@ US$5.280.7% of flowCommon StockSEC:0001179110-16-031541:3
- 5,606 shares@ US$5.080.2% of flowCommon StockSEC:0001179110-16-031541:4
- 100,000 shares@ US$32.1928.0% of flowCommon StockSEC:0001179110-16-031541:5
- 95,000 shares@ US$1.801.5% of flowCommon StockSEC:0001179110-16-027530:0
- 23,022 shares@ US$5.281.0% of flowCommon StockSEC:0001179110-16-027490:0
- 7,396 shares@ US$34.182.2% of flowCommon StockSEC:0001179110-16-027490:1
- 20,626 shares@ US$34.926.2% of flowCommon StockSEC:0001179110-16-027490:2
- 30,501 shares@ US$5.281.4% of flowCommon StockSEC:0001179110-16-027490:3
- 28,111 shares@ US$33.188.1% of flowCommon StockSEC:0001179110-16-027490:4
- 2,390 shares@ US$34.220.7% of flowCommon StockSEC:0001179110-16-027490:5
- 41,477 shares@ US$5.281.9% of flowCommon StockSEC:0001179110-16-027490:6
- 31,040 shares@ US$33.589.0% of flowCommon StockSEC:0001179110-16-027490:7
- 10,437 shares@ US$34.263.1% of flowCommon StockSEC:0001179110-16-027490:8
- 24,090 shares@ US$5.081.0% of flowCommon StockSEC:0001179110-16-025240:0
- 36,590 shares@ US$33.0410.3% of flowCommon StockSEC:0001179110-16-025240:1
- 37,623 shares@ US$5.081.6% of flowCommon StockSEC:0001179110-16-025240:2
- 37,623 shares@ US$33.0410.6% of flowCommon StockSEC:0001179110-16-025240:3
- 25,787 shares@ US$5.081.1% of flowCommon StockSEC:0001179110-16-025240:4
- 25,787 shares@ US$33.177.3% of flowCommon StockSEC:0001179110-16-025240:5
- 17,500 shares0Common StockSEC:0001179110-16-021174:0
- 19,000 shares@ US$5.08Common StockSEC:0001179110-15-013969:0
- 6,548 shares@ US$24.01Common StockSEC:0001179110-15-013969:1
25 of 90 declarations
